Table 5. Summary of adverse events and NCI CTCAE severity grade 3 or higher related to chemotherapy.
| Overall (n=1,712) No. (%) |
Anthracycline (n=1,353) No. (%) |
Non-anthracycline (n=359) No. (%) |
|
|---|---|---|---|
| Any related AEs | 1,326 (77.5) | 1,054 (77.9) | 272 (75.8) |
| Most common AEs | |||
| Alopecia | 707 (41.3) | 554 (40.9) | 153 (42.6) |
| Nausea | 643 (37.6) | 552 (40.8) | 91 (25.3) |
| Neutropenia | 457 (26.7) | 394 (29.1) | 63 (17.5) |
| Vomiting | 394 (23) | 352 (26) | 42 (11.7) |
| Peripheral sensory neuropathy | 219 (12.8) | 186 (13.7) | 33 (9.2) |
| NCI CTCAE severity grade 3 or higher | 603 (35.2) | 482 (35.6) | 121 (33.7) |
| Neutropenia | 342 (20) | 292 (21.6) | 50 (13.9) |
| Vomiting | 27 (1.6) | 25 (1.8) | 2 (0.6) |
NCI CTCAE=National Cancer Institute Common Terminology Criteria for Adverse Events; AEs=adverse events.